Amgen Inc Stock Price Prediction
| AMGN Stock | USD 295.17 5.27 1.82% |
Oversold Vs Overbought
57
Oversold | Overbought |
Quarterly Earnings Growth 0.621 | EPS Estimate Next Quarter 5.46 | EPS Estimate Current Year 19.5722 | EPS Estimate Next Year 20.6404 | Wall Street Target Price 334.0596 |
Using Amgen hype-based prediction, you can estimate the value of Amgen Inc from the perspective of Amgen response to recently generated media hype and the effects of current headlines on its competitors.
Amgen Inc Hype to Price Pattern
Investor biases related to Amgen's public news can be used to forecast risks associated with an investment in Amgen. The trend in average sentiment can be used to explain how an investor holding Amgen can time the market purely based on public headlines and social activities around Amgen Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Amgen's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Amgen.
The fear of missing out, i.e., FOMO, can cause potential investors in Amgen to buy its stock at a price that has no basis in reality. In that case, they are not buying Amgen because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Amgen after-hype prediction price | USD 289.58 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Amgen |
Amgen After-Hype Price Prediction Density Analysis
As far as predicting the price of Amgen at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Amgen or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Amgen, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Amgen Estimiated After-Hype Price Volatility
In the context of predicting Amgen's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Amgen's historical news coverage. Amgen's after-hype downside and upside margins for the prediction period are 288.01 and 291.15, respectively. We have considered Amgen's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Amgen is very steady at this time. Analysis and calculation of next after-hype price of Amgen Inc is based on 3 months time horizon.
Amgen Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Amgen is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Amgen backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Amgen, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.16 | 1.57 | 0.32 | 0.03 | 9 Events / Month | 5 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
295.17 | 289.58 | 0.11 |
|
Amgen Hype Timeline
Amgen Inc is presently traded for 295.17. The entity has historical hype elasticity of -0.32, and average elasticity to hype of competition of -0.03. Amgen is forecasted to decline in value after the next headline, with the price expected to drop to 289.58. The average volatility of media hype impact on the company price is about 79.7%. The price decrease on the next news is expected to be -0.11%, whereas the daily expected return is presently at -0.16%. The volatility of related hype on Amgen is about 720.92%, with the expected price after the next announcement by competition of 295.14. About 81.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 2.07. Amgen Inc recorded earning per share (EPS) of 7.83. The entity last dividend was issued on the 18th of November 2024. The firm had 2:1 split on the 22nd of November 1999. Given the investment horizon of 90 days the next forecasted press release will be in about 9 days. Check out Amgen Basic Forecasting Models to cross-verify your projections.Amgen Related Hype Analysis
Having access to credible news sources related to Amgen's direct competition is more important than ever and may enhance your ability to predict Amgen's future price movements. Getting to know how Amgen's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Amgen may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| MRK | Merck Company | (1.61) | 7 per month | 0.00 | (0.28) | 1.73 | (2.13) | 4.89 | |
| PFE | Pfizer Inc | 0.49 | 9 per month | 0.00 | (0.22) | 2.17 | (2.45) | 8.17 | |
| EHGO | Eshallgo Class A | 0.09 | 1 per month | 4.97 | 0.17 | 14.29 | (8.22) | 46.99 | |
| ASYS | Amtech Systems | (0.14) | 7 per month | 0.00 | (0.09) | 3.76 | (4.33) | 10.29 | |
| GFI | Gold Fields Ltd | (0.46) | 12 per month | 0.00 | (0.07) | 4.52 | (5.41) | 14.93 | |
| AGZNF | Aegean Airlines SA | 0.00 | 0 per month | 0.00 | (0.24) | 0.00 | 0.00 | 10.55 | |
| LPG | Dorian LPG | 0.03 | 9 per month | 0.00 | (0.29) | 2.97 | (4.58) | 9.93 | |
| FORM | FormFactor | (0.44) | 10 per month | 0.00 | (0.11) | 4.53 | (5.08) | 19.85 | |
| CNK | Cinemark Holdings | 0.08 | 12 per month | 1.24 | 0.09 | 3.60 | (2.45) | 7.52 |
Amgen Additional Predictive Modules
Most predictive techniques to examine Amgen price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Amgen using various technical indicators. When you analyze Amgen charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Amgen Predictive Indicators
The successful prediction of Amgen stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Amgen Inc, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Amgen based on analysis of Amgen hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Amgen's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Amgen's related companies. | 2021 | 2022 | 2023 | 2024 (projected) | Dividend Yield | 0.0313 | 0.0297 | 0.0296 | 0.0185 | Price To Sales Ratio | 4.94 | 5.37 | 5.47 | 9.47 |
Story Coverage note for Amgen
The number of cover stories for Amgen depends on current market conditions and Amgen's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Amgen is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Amgen's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Amgen Short Properties
Amgen's future price predictability will typically decrease when Amgen's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Amgen Inc often depends not only on the future outlook of the potential Amgen's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Amgen's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 538 M | |
| Cash And Short Term Investments | 10.9 B |
Check out Amgen Basic Forecasting Models to cross-verify your projections. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amgen. If investors know Amgen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amgen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.621 | Dividend Share 8.88 | Earnings Share 7.83 | Revenue Per Share 60.641 | Quarterly Revenue Growth 0.232 |
The market value of Amgen Inc is measured differently than its book value, which is the value of Amgen that is recorded on the company's balance sheet. Investors also form their own opinion of Amgen's value that differs from its market value or its book value, called intrinsic value, which is Amgen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amgen's market value can be influenced by many factors that don't directly affect Amgen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amgen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amgen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amgen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.